Avia Logo

Compare Products


Jump to:
Categories
Solutions
Description
Compatibility Level
Clients
Use cases
EHR integrations
Client types
Awards
Differentiators
Keywords
Media
Company details
Jump to:
Categories
Solutions
Description
Compatibility Level
Clients
Use cases
EHR integrations
Client types
Awards
Differentiators
Keywords
Media
Company details

Categories

Solutions

Description

Product Description:

A Health Equity Solution - AccendoWave Benchmarks Pain Data with Machine Learning Technology. We have the Largest Global Real-Time Database on Pain. AccendoWave's Digital Opioid Alternative does real time assessment of pain and nausea. AccendoWave is considered a clinically validated opioid alternative. AccendoWave technology has been proven to reduce pain in 83% of patients in a clinical setting.

About AccendoWave:

AccendoWave, a Pain Data Company with machine learning pain measurement & management technology. 

AccendoWave, a Top 4 Global Best in Class Health Equity Solution and Top 15 Global Best in Class Remote Monitoring Company, benchmarks pain data (specialty, gender, age) with machine learning technology to eliminate bias, improve outcomes and reduce health care costs. Incubated by HCA - Samsung and AT&T are our partners.

 

AccendoWave has nine objective pain datbases (Women's Health, Oncology, Labor & Delivery, Emergency Room, Ortho/Neuro, Med/Surg, ICU, Senior, Adults). 

Pain is the primary reason patients access healthcare - so pain is a primary driver of health care cost. Pain levels don't show up in claims data nor can objective pain levels be extracted from EHR's. So Employers/Health Plans/Hospitals/Government have no visibility into or data on the primary driver of health care costs.  

Pain has a bias problem. There is extensive research & RWD showing bias: women and pain, ethnicity and pain, seniors and pain. 

The real world data from our health care systems is crushinly similar. #1 complaint of patients of color is that their pain isn't believed. This results in less pain medicine given to these patients and later stage cancer diagnosis.  

Given the new state, health plan and CMS initiatives on health equity, health systems must provide data and focus on this pain bias problem. 

Additionally, a patient whose pain isn't believed doesn't trust their provider or health care system, and their patient experience is a zero. 

AccendoWave provides data and insights to eliminate pain bias, improve care and reduce stakeholder healthcare costs. 

AccendoWave utilizes full spectrum brain analysis and deep learning algorithms to measure & monitor discomfort/pain. AccendoWave has four products: 

1. Digital Opioid Alternative (Hospital & Home) Value Proposition - Reduce Opioid Usage, Reduce Length of Stay, and Improve Patient Satisfaction. Most Cost Effective Choice to Meet The Joint Commission Non Pharma Pain Treatment Modality Requirement. Home - to reduce opioid usage in the transition from hospital to home. *AT&T reimburses for AccendoWave for 30 days post hospital discharge. 

2. UV Sanitizing & Charging Technology (Hospital) Value Proposition - Infection Control and Simplified Charging for AccendoWave Hospital Technology. 

3. Top 15 Global Best in Class Remote Pain Monitoring Technology. Value Proposition - Data Insight into Pain - A Primary Driver of Cost & Outcomes. *AT&T reimburses for AccendoWave for 30 days post hospital discharge. 

4. Largest Global Real-Time Database on Pain with Nine Seperate Objective Pain Databases. Value Proposition - Objective Pain Benchmarked Data to Address Health Equity, Improve Operational Performance, Reduce Costs, Improve Patient Satisfaction, and Demonstrate Outcomes. 

Product Description:

A Health Equity Solution - AccendoWave's Real-Time Benchmarked Pain Database (specialty, gender, age)

About AccendoWave:

AccendoWave, a Pain Data Company with machine learning pain measurement & management technology. 

AccendoWave, a Top 4 Global Best in Class Health Equity Solution and Top 15 Global Best in Class Remote Monitoring Company, benchmarks pain data (specialty, gender, age) with machine learning technology to eliminate bias, improve outcomes and reduce health care costs. Incubated by HCA - Samsung and AT&T are our partners.

 

AccendoWave has nine objective pain datbases (Women's Health, Oncology, Labor & Delivery, Emergency Room, Ortho/Neuro, Med/Surg, ICU, Senior, Adults). 

Pain is the primary reason patients access healthcare - so pain is a primary driver of health care cost. Pain levels don't show up in claims data nor can objective pain levels be extracted from EHR's. So Employers/Health Plans/Hospitals/Government have no visibility into or data on the primary driver of health care costs.  

Pain has a bias problem. There is extensive research & RWD showing bias: women and pain, ethnicity and pain, seniors and pain. 

The real world data from our health care systems is crushinly similar. #1 complaint of patients of color is that their pain isn't believed. This results in less pain medicine given to these patients and later stage cancer diagnosis.  

Given the new state, health plan and CMS initiatives on health equity, health systems must provide data and focus on this pain bias problem. 

Additionally, a patient whose pain isn't believed doesn't trust their provider or health care system, and their patient experience is a zero. 

AccendoWave provides data and insights to eliminate pain bias, improve care and reduce stakeholder healthcare costs. 

AccendoWave utilizes full spectrum brain analysis and deep learning algorithms to measure & monitor discomfort/pain. AccendoWave has four products: 

1. Digital Opioid Alternative (Hospital & Home) Value Proposition - Reduce Opioid Usage, Reduce Length of Stay, and Improve Patient Satisfaction. Most Cost Effective Choice to Meet The Joint Commission Non Pharma Pain Treatment Modality Requirement. Home - to reduce opioid usage in the transition from hospital to home. *AT&T reimburses for AccendoWave for 30 days post hospital discharge. 

2. UV Sanitizing & Charging Technology (Hospital) Value Proposition - Infection Control and Simplified Charging for AccendoWave Hospital Technology. 

3. Top 15 Global Best in Class Remote Pain Monitoring Technology. Value Proposition - Data Insight into Pain - A Primary Driver of Cost & Outcomes. *AT&T reimburses for AccendoWave for 30 days post hospital discharge. 

4. Largest Global Real-Time Database on Pain with Nine Seperate Objective Pain Databases. Value Proposition - Objective Pain Benchmarked Data to Address Health Equity, Improve Operational Performance, Reduce Costs, Improve Patient Satisfaction, and Demonstrate Outcomes. 

Compatibility level

Select which hospital or health system you work at and see a personalized compatibility level.

Clients

Select which hospital or health system you work at and see the client list

Use Cases

Description:
AccendoWave is an enterprise solution and is deployed in four to six hospital departments. The departments include: ED, ICU, Ortho, MS, L&D, Oncology/IMC. AccendoWave works very closely with the hospital pharmacy department. Each day pharmacy identifies high opioid users in the hospital and AccendoWave staff visits each patient to offer a non pharma opioid alternative to reduce hospital opioid usage.
Pediatric use cases:
AccendoWave is being used in pediatric departments as well as in the PICU.
Users:
Adult and pediatric patients experiencing pain in the hospital.
Description:

Overview: Pain is the primary driver of cost as pain is the primary reason patients access health care. Hospitals have no visibility into objective pain level data as pain data can't be extracted from the EHR.


Health Equity - Many patients feel their pain isn't believed (women and pain, ethnicity and pain, seniors and pain). There is growing body of research and real world data demonstrating pain bias.


Hospital Inpatient: Reduction in Length of Stay by comparing individual patient pain to AccendoWave's benchmarked pain databases to improve care pathways and reduce healthcare costs.

Hospital at Home: Measure Individual patient pain and compare pain levels to AccendoWave benchmarked pain databases to improve care pathways and reduce healthcare costs.

Pediatric use cases:

Children are largely unable to articulate their pain levels. AccendoWave can be used to understand pediatric pain by measuring individual pain and comparing that pain to AccendoWave's pediatric pain database.

Users:

1. Hospitals 2. Medicare Advantage Health Plans 3. Pharmaceutical Companies 4. Government 5.Medical Device Companies 6.Data Companies 7. Technology Companies

Professionals: Nurses, Nurse Practitioners, Techs, Psychologists, Care Coordinators

EHR Integrations

Integrations:

Other

EMR Integration & Relevant Hardware:

Use case dependent

EMRs Supported:

Other

Hardware Compatibility:

Other

Integrations:

Other

EMR Integration & Relevant Hardware:

Use case dependent

EMRs Supported:

Other

Hardware Compatibility:

Other

Client Types

None provided
None provided

Awards

edit-media
edit-media

Differentiators

Differentiators vs EHR Functionality:

Hospital Internal Options for Pain Measurement & Pain Monitoring: 1. Subjective pain scale which is subject to bias for those who can articulate pain. 2. Guessing pain levels for patients unable to communicate pain. Non Pharma Alternatives: Hospitals rarely provide complementary therapy for patient pain distraction and if they do it is not readily viable for every patient in multiple departments. Hospitals have no ability to provide pain data analytics using their Electronic Health Records.

Differentiators vs Competitors:

AccendoWave Technology Provides Three Solutions in One: 1. Pain Distraction - AccendoWave's competition is Complementary Therapy and Virtual Reality. Virtual Reality and Complementary Therapy provide no individual pain data analytics. 2. Pain Measurement & Monitoring - AccendoWave is the only company that can measure and monitor individual pain 3. Pain Data Analytics - AccendoWave has the largest global real time benchmarked pain database.

Differentiators vs EHR Functionality:

AccendoWave has the unique ability to provide objective pain level data. Pain level data can not be extracted from EHR platforms.

Differentiators vs Competitors:

AccendoWave is the global leader in objective pain level data. Pain level is linked to length of stay, opioid usage, and readmissions. No competitor according to Lazard has the ability to quantify individual pain level data and provide a comparison of individual pain data to a global pain database.

Keywords

Images

1 of 3

edit-media
Milken Institute Lawrence.jpg

1 of 1

edit-media
LI | New Health Application of AI.png

Videos

1 of 4

edit-media
aw_news_06.01.19

1 of 1

edit-media
AccendoWave - UCSF Health Awards New Health Application of AI Quarterfinalist Spotlight

Downloads

Alternatives

Company Details

Founded in 2012

Founded in 2012

team illustration
Share your product comparison with your collegues.

Need help narrowing down products?

Add more criteria to see your compatibility level for every vendor. It only takes a few minutes, just create a free account to get started.
back to top